Radiosynthesis and initial evaluation of 18F labeled nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide

Nuclear Medicine and Biology

Volumn 40, Issue 3, 2013, Pages 387-394

  Yamamoto, Fumihiko ^a,b   Yamahara, Ryo ^c   Makino, Akira ^c,d   Kurihara, Kensuke ^b,d   Tsukada, Hideo ^e   Hara, Eri ^c   Hara, Isao ^c   Kizaka Kondoh, Shinae ^f   Ohkubo, Yasuhito ^a   Ozeki, Eiichi ^c   Kimura, Shunsaku ^b,d  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c SHIMADZU CORPORATION   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e CENTRAL RESEARCH LABORATORY   (Japan)

^f NONE   (Japan)

Author keywords

Fluorine 18; Lactosome; Mice; Nanocarrier; PET; Tumor imaging

Indexed keywords

4 FLUOROBENZOYL POLYLACTIC ACID F 18; CONTRAST MEDIUM; DEPSIPEPTIDE; FLUORINE 18; FLUORINE LACTOSOME F 18; NANOCARRIER; POLY(LACTIC ACID) BLOCK POLY(SARCOSINE); POLYMER; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; FILM HYDRATION METHOD; FLUORESCENCE; ISOTOPE LABELING; MOUSE; NEAR INFRARED FLUORESCENCE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; TISSUE DISTRIBUTION;

ANIMALS; DEPSIPEPTIDES; FEMALE; FLUORINE RADIOISOTOPES; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICE; MICELLES; NANOSTRUCTURES; POLYESTERS; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY;

EID: 84875245502     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.12.008     Document Type: Article

References (33)

1. Chapter 1. What was the historical background? Annual Health, Labour and Welfare Report 2010-2011 Part 1 2011, 5-31. The Ministry of Health, Labour and Welfare of Japan (Ed.).
2. Weissleder R., Mahmood U. Molecular imaging. Radiology 2001, 219:316-333.
3. Herschman H.R. Molecular imaging: looking at problems, seeing solutions. Science 2003, 302:605-608.
4. Sharma P., Brown S., Walter G., Santra S., Moudgil B. Nanoparticles for bioimaging. Adv Colloid Interface Sci 2006, 123-126:471-485.
5. Bouchelouche K., Oehr P. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol 2008, 179:34-45.
6. Wang Z., Chen J.Q. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol 2011, 11:19.
7. Vallabhajosula S., Solnes L., Vallabhajosula B. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?. Semin Nucl Med 2011, 41:246-264.
8. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010, 21:797-802.
9. 18F]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography. J Med Chem 2007, 50:6454-6457.
10. Oku N., Yamashita M., Katayama Y., Urakami T., Hatanaka K., Shimizu K., et al. PET imaging of brain cancer with positron emitter-labeled liposomes. Int J Pharm 2011, 403:170-177.
11. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2005, 16:122-130.
12. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011, 63:136-151.
13. Lammers T., Hennink W.E., Storm G. Tumour-targeted nanomedicines: principles and practice. Br J Cancer 2008, 99:392-397.
14. Lukyanov A.N., Hartner W.C., Torchilin V.P. Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release 2004, 94:187-193.
15. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001, 41:189-207.
16. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
17. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 2003, 63:8977-8983.
18. Bermudez H., Hammer D.A., Discher D.E. Effect of bilayer thickness on membrane bending rigidity. Langmuir 2004, 20:540-543.
19. Obst M., Steinbuchel A. Microbial degradation of poly(amino acid)s. Biomacromolecules 2004, 5:1166-1176.
20. Welch M.J., Hawker C.J., Wooley K.L. The advantages of nanoparticles for PET. J Nucl Med 2009, 50:1743-1746.
21. Liu Y., Welch M.J. Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. Bioconjug Chem 2012, 23:671-682.
22. Dai Z., Piao L., Zhang X., Deng M., Chen X., Jing X. Probing the micellization of diblock and triblock copolymers of poly(l-lactide) and poly(ethylene glycol) in aqueous and NaCl salt solutions. Colloid Polym Sci 2004, 282:343-350.
23. Dewachter P., Mouton-Faivre C. Anaphylaxis to macrogol 4000 after a parenteral corticoid injection. Allergy 2005, 60:705-706.
24. Makino A., Yamahara R., Ozeki E., Kimura S. Preparation of novel polymer assemblies, "lactosome", composed of poly(L-lactic acid) and poly(sarcosine). Chem Lett 2007, 36:1220-1221.
25. Makino A., Kizaka-Kondoh S., Yamahara R., Hara I., Kanzaki T., Ozeki E., et al. Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. Biomaterials 2009, 30:5156-5160.
26. Tanisaka H., Kizaka-Kondoh S., Makino A., Tanaka S., Hiraoka M., Kimura S. Near-infrared fluorescent labeled peptosome for application to cancer imaging. Bioconjug Chem 2008, 19:109-117.
27. Makino A., Kimura S. Preparation of peptide- and protein-based molecular assemblies and their utilizations as nanocarriers for tumor imaging. React Funct Polym 2011, 71:272-279.
28. 18F]fluoro-L-ascorbic acid. Appl Radiat Isot 1992, 43:633-639.
29. 18F]fluoro-L-ascorbic acid: tissue biodistribution in ascorbic acid-deficiency and RG-C6 glioma bearing rats. Radioisotopes 1995, 44:93-98.
30. 18F]fluoroethyl)nortropane) as a dopamine transporter ligand: a PET study in the conscious monkey brain. Synapse 2004, 54:37-45.
31. 18F]SFB using fully automated microreactor-based continuous flow system. J Label Compd Radiopharm 2011, 54:S557.
32. 18F]SFB) for protein labeling. J. Labelled Compd. Radiopharm 2008, 51:68-71.
33. 18F. Nat Protoc 2006, 1:1655-1661.